Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 3
- Cultivation
Releaf and Glass Pharms to Offer THCV Range Aimed at Weight Management
UK medical cannabis cultivator Glass Pharms has partnered with leading clinic Releaf to bring cannabis containing meaningful levels of THCV (Tetrahydrocannabivarin), a cannabinoid linked to reduced appetite in emerging research, to patients in the UK for the first time since 1973.
- Medical Cannabis
Spain’s Medical Cannabis Framework Finally Reaches Patients, But Rollout is ‘Not the Finish Line’
Spain’s medical cannabis framework will finally start reaching patients over the coming days and weeks, marking a significant milestone in a four-year battle for access.
- Clinical Research
Helius Therapeutics to Supply New Phase 2 Cannabis Sleep Trial
Helius Therapeutics has today announced a supply agreement with the University of Auckland for a new Phase 2 trial into cannabis as a sleep aid for patients which chronic back pain.
- Hemp Industry
As the EU Moves to Protect Hemp, Ireland Still Treats It as a Drug
The criminalisation of industrial hemp and CBD flower across European nations has, sadly, only continued to spread since we published our last edition of ‘Hemp Wars’ in May.
- Data & Analysis
UK vs Germany – Medical Cannabis Products & Prices (2026 Update)
Over the last decade, the European medical cannabis landscape has seen a significant surge of new products entering the market, providing patients, especially in the UK and Germany, with a greater variety than ever before.
- Medical Cannabis
France’s Final Medical Cannabis Decree Could Be Complete in the ‘Coming Weeks’
Frances’ incoming medical cannabis framework is expected to take the final step before it can be signed into law in the ‘coming weeks’.
- Cultivation
Irradiated Medical Cannabis and the Science Behind the Debate
James Duckenfield, CEO of Glass Pharms®, examines what irradiation changes in medical cannabis flower, what it leaves behind, and why understanding microbial quality requires a closer look at the science.
- Opinion
‘Legislation Opens a Market, It Does Not Build One’: APAC’s Future Leaders Will Be the Ones Who Do
After closing the Agential Cannabis conference in Bangkok last month, Stephen Murphy, founder and CEO of Prohibition Partners, considers how medicinal cannabis in the Asia-Pacific region is taking shape and what will determine leadership in the region over the next five years.
- Hemp Industry
Hemp Could Be the UK’s Overlooked Net Zero Solution, New Report Argues
The UK’s Cannabis Industry Council (CIC) has launched a new report calling for industrial hemp regulation to be transferred from the Home Office to the Department for Environment, Food and Rural Affairs (DEFRA), arguing that the current licensing regime is holding back a crop capable of helping the UK meet its binding Net Zero commitments.
- M&A Activity
The Aurora Ménage à Trois: Three Shifts in Seven Days
Curaleaf Holdings’ battle to acquire Aurora Cannabis has shifted in favour of the Canadian producer on multiple fronts over the last week.
- Investment & Finance
Cannabis Stocks in 2026: What Is Listed, What Is Next and How the Market Trades
Why are cannabis listings so relevant in 2026?
- Medical Cannabis
‘Unacceptable Failure of Duty of Care’: Bedrocan Bankruptcy Leaves Life-Saving Medicine Frozen in Storage
Bedrocan’s Dutch entities have officially been declared bankrupt, leaving stocks of life-saving medicinal cannabis in the hands of court-appointed administrators who cannot release them.
